Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis: Management of Glomerulonephritis in Adults

被引:28
|
作者
Cybulsky, Andrey V. [1 ]
Walsh, Michael [2 ]
Knoll, Greg [3 ]
Hladunewich, Michelle [4 ]
Bargman, Joanne [4 ]
Reich, Heather [4 ]
Humar, Atul [5 ]
Samuel, Susan [6 ]
Bitzan, Martin [7 ]
Zappitelli, Michael [7 ]
Dart, Allison [8 ]
Mammen, Cherry [9 ]
Pinsk, Maury [6 ]
Muirhead, Norman [10 ]
机构
[1] McGill Univ, Dept Med, Montreal, PQ, Canada
[2] McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada
[3] Univ Ottawa, Dept Med, Div Nephrol, Ottawa, ON, Canada
[4] Univ Toronto, Dept Med, Toronto, ON, Canada
[5] Univ Alberta, Edmonton, AB, Canada
[6] Univ Alberta, Dept Pediat, Edmonton, AB, Canada
[7] Montreal Childrens Hosp, Montreal, PQ H3H 1P3, Canada
[8] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada
[9] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada
[10] Univ Western Ontario, Dept Med, Div Nephrol, London, ON N6A 5A5, Canada
关键词
Clinical practice guideline implementation; KDIGO (Kidney Disease: Improving Global Outcomes); Canadian Society of Nephrology (CSN); nephrotic syndrome; glomerulonephritis; ANTIBODY-ASSOCIATED VASCULITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TERM-FOLLOW-UP; IDIOPATHIC MEMBRANOUS NEPHROPATHY; CHRONIC KIDNEY-DISEASE; DENSE DEPOSIT DISEASE; IGA NEPHROPATHY; LONG-TERM; MYCOPHENOLATE-MOFETIL; OXFORD CLASSIFICATION;
D O I
10.1053/j.ajkd.2013.12.001
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The KDIGO (Kidney Disease: Improving Global Outcomes) clinical practice guideline for management of glomerulonephritis was recently released. The Canadian Society of Nephrology convened a working group to review the recommendations and comment on their relevancy and applicability to the Canadian context. A subgroup of adult nephrologists reviewed the guideline statements for management of glomerular disease in adults and agreed with most of the guideline statements developed by KDIGO. This commentary highlights areas for which there is lack of evidence and areas in need of translation of evidence into clinical practice. Areas of controversy or uncertainty, including the choice of second-line agents, are discussed in more detail. Existing practice variation also is addressed. The relevance of treatment recommendations to the Canadian practitioner is discussed. (C) 2014 by the National Kidney Foundation, Inc.
引用
收藏
页码:363 / 377
页数:15
相关论文
共 50 条
  • [32] KDOQI US Commentary on the 2009 KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
    Bia, Margaret
    Adey, Deborah B.
    Bloom, Roy D.
    Chan, Laurence
    Kulkarni, Sanjay
    Tomlanovich, Steven
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 56 (02) : 189 - 218
  • [34] KDOQI US Commentary on the KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in CKD
    Gordon, Craig E.
    Balk, Ethan M.
    Becker, Bryan N.
    Crooks, Peter A.
    Jaber, Bertrand L.
    Johnson, Cynda A.
    Michael, Maureen A.
    Pereira, Brian J. G.
    Uhlig, Katrin
    Levin, Adeera
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (05) : 811 - 825
  • [35] KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C
    Roth, David
    Bloom, Roy D.
    Molnar, Miklos Z.
    Reese, Peter P.
    Sawinski, Deirdre
    Sise, Meghan E.
    Terrault, Norah A.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (05) : 665 - 683
  • [36] Executive Summary of the Korean Society of Nephrology 2021 Clinical Practice Guideline for Optimal Hemodialysis Treatment
    Jung, Ji Yong
    Yoo, Kyung Don
    Kang, Eunjeong
    Kang, Hee Gyung
    Kim, Su Hyun
    Kim, Hyoungnae
    Kim, Hyo Jin
    Park, Tae-Jin
    Suh, Sang Heon
    Jeong, Jong Cheol
    Choi, Ji-Young
    Hwang, Young-Hwan
    Choi, Miyoung
    Kim, Yae Lim
    Oh, Kook-Hwan
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2021, 40 (04) : 578 - 595
  • [37] Executive summary of the Korean Society of Nephrology 2021 clinical practice guideline for optimal hemodialysis treatment
    Jung, Ji Yong
    Yoo, Kyung Don
    Kang, Eunjeong
    Kang, Hee Gyung
    Kim, Su Hyun
    Kim, Hyoungnae
    Kim, Hyo Jin
    Park, Tae-Jin
    Suh, Sang Heon
    Jeong, Jong Cheol
    Choi, Ji-Young
    Hwang, Young-Hwan
    Choi, Miyoung
    Kim, Yae Lim
    Oh, Kook-Hwan
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2022, 37 (04) : 701 - 718
  • [38] Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease
    Cheung, Alfred K.
    Chang, Tara, I
    Cushman, William C.
    Furth, Susan L.
    Hou, Fan Fan
    Ix, Joachim H.
    Knoll, Gregory A.
    Muntner, Paul
    Pecoits-Filho, Roberto
    Sarnak, Mark J.
    Tobe, Sheldon W.
    Tomson, Charles R., V
    Lytvyn, Lyubov
    Craig, Jonathan C.
    Tunnicliffe, David J.
    Howell, Martin
    Tonelli, Marcello
    Cheung, Michael
    Earley, Amy
    Mann, Johannes F. E.
    KIDNEY INTERNATIONAL, 2021, 99 (03) : 559 - 569
  • [39] KDIGO 2012 Clinical Practice Guideline CKD classification rules out creatinine clearance 24 hour urine collection?
    Ognibene, A.
    Grandi, G.
    Lorubbio, M.
    Rapi, S.
    Salvadori, B.
    Terreni, A.
    Veroni, F.
    CLINICAL BIOCHEMISTRY, 2016, 49 (1-2) : 85 - 89
  • [40] Renal association commentary on the KDIGO (2017) clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD
    Burton, James O.
    Goldsmith, David J.
    Ruddock, Nicki
    Shroff, Rukshana
    Wan, Mandy
    BMC NEPHROLOGY, 2018, 19